首页 > 最新文献

Gynecology and pelvic medicine最新文献

英文 中文
Sacrocolpopexy: anatomical landmarks, clinical appliance and 3-year outcomes Sacrocolpopexy:解剖标志、临床应用和3年疗效
Pub Date : 2021-01-01 DOI: 10.21037/gpm-21-18
A. Popov, I. Klyushnikov, A. Fedorov, A. Koval, S. Tyurina, A. Idashkin
Background: Sacrocolpopexy (SCP) is one of the most popular and approved surgical methods of correction of the apical pelvic organ prolapse (POP). This intervention has been adjusted to a laparoscopic approach for more than 20 years. Mini-invasive surgery’s advantages combined with dependable results of augmentation allowed to adopt it worldwide in most urogynecological wards. Nevertheless, SCP is not so basic in performance, so it can cause many difficulties during surgery, especially at first. This article describes step-by-step instruction of promontofixation performed either laparoscopically or robotically with the classic two-strap technique, focusing on anatomical landmarks and present our anatomical, and functional long-term outcomes covering up to 7 years of observation. Methods: Intervention could be divided into two big steps: (I) wide dissection and retroperitoneal tissue preparation combined with subtotal hysterectomy; (II) fixation of the mesh with non-absorbable sutures and peritoneal closure. During 2013–2020 years in Moscow Regional Scientific Research Institute of Obstetrics and Gynecology SCP was performed in 387 patients, 193 using laparoscopic approach and 194 robotic-assisted. For recurrence cases of POP, we took the criteria by International UroGynecological Association: direct or indirect genital prolapse reaching or going below the level of the hymen (POP-Q ≥ stage 2b) for objective recurrence. Functional outcomes were evaluated by international validated questionnaires by achieving the minimal clinical important difference (MCID) in points, previously approved by studies. Results: Our 3-year long-term outcomes resulted in 29 cases of POP recurrence (8.1%). Twenty-six of them were resulted in cystocele (7.3%), 4 (1.1%) in rectocele and 2 (0.6%) in apical prolapse. Clinical improvement based on Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire-12 (PISQ-12) score was met in 132 (66.3%) patients, 250 (70.0%) of women improved pelvic floor dysfunction Pelvic Floor Distress Inventory-20 (PFDI-20) and 205 (57.4%) of patients improved their social life according to Pelvic Floor Inventory Questionnaire-7 (PFIQ-7) score. Conclusions: Our long-term results reflect, that this method may not be advised in cases with anterior-apical prolapse, because of the high risk for prolapse recurrence (7.3%) and surgical imperfection of safe and avascular dissection of the anterior vaginal wall. However, in patients with complex and posterior-apical prolapse, such intervention still should be considered as a “gold standard”. 8
背景:Sacrocolpopexy(SCP)是最受欢迎和认可的矫正顶端盆腔器官脱垂(POP)的手术方法之一。20多年来,这种干预措施一直被调整为腹腔镜方法。微创手术的优势加上可靠的隆胸效果,使其得以在全球大多数泌尿生殖科病房采用。然而,SCP在性能上并不那么基础,因此在手术过程中会造成许多困难,尤其是在最初。本文介绍了用腹腔镜或机器人用经典的双带技术进行海角固定的分步指导,重点介绍了解剖标志,并介绍了我们长达7年的解剖和功能长期结果。方法:干预可分为两大步骤:(I)广泛剥离腹膜后组织制备结合子宫次全切除术;(II) 用不可吸收缝线固定网片并腹膜闭合。在2013-2020年期间,莫斯科地区妇产科科学研究所对387名患者进行了SCP,其中193名使用腹腔镜方法,194名使用机器人辅助。对于POP复发病例,我们采用国际泌尿妇科协会的标准:直接或间接生殖器脱垂达到或低于处女膜水平(POP-Q≥2b期),以客观复发。通过国际验证的问卷评估功能结果,在积分上达到最小临床重要差异(MCID),这一点先前已得到研究的批准。结果:我们的3年长期结果导致29例POP复发(8.1%)。其中26例发生膀胱膨出(7.3%),4例发生直肠前突(1.1%),2例发生根尖脱垂(0.6%)。132名(66.3%)患者达到了基于盆腔器官脱垂/尿失禁性问卷-12(PISQ-12)评分的临床改善,250名(70.0%)女性改善了盆底功能障碍盆底疼痛量表-20(PFDI-20),205名(57.4%)患者根据盆底量表-7(PFIQ-7)评分改善了社交生活。结论:我们的长期结果表明,这种方法可能不建议用于前顶端脱垂的病例,因为脱垂复发的风险很高(7.3%),而且阴道前壁的安全无血管剥离手术不完善。然而,对于复杂和后根尖脱垂的患者,这种干预仍然应该被视为“金标准”。8.
{"title":"Sacrocolpopexy: anatomical landmarks, clinical appliance and 3-year outcomes","authors":"A. Popov, I. Klyushnikov, A. Fedorov, A. Koval, S. Tyurina, A. Idashkin","doi":"10.21037/gpm-21-18","DOIUrl":"https://doi.org/10.21037/gpm-21-18","url":null,"abstract":"Background: Sacrocolpopexy (SCP) is one of the most popular and approved surgical methods of correction of the apical pelvic organ prolapse (POP). This intervention has been adjusted to a laparoscopic approach for more than 20 years. Mini-invasive surgery’s advantages combined with dependable results of augmentation allowed to adopt it worldwide in most urogynecological wards. Nevertheless, SCP is not so basic in performance, so it can cause many difficulties during surgery, especially at first. This article describes step-by-step instruction of promontofixation performed either laparoscopically or robotically with the classic two-strap technique, focusing on anatomical landmarks and present our anatomical, and functional long-term outcomes covering up to 7 years of observation. Methods: Intervention could be divided into two big steps: (I) wide dissection and retroperitoneal tissue preparation combined with subtotal hysterectomy; (II) fixation of the mesh with non-absorbable sutures and peritoneal closure. During 2013–2020 years in Moscow Regional Scientific Research Institute of Obstetrics and Gynecology SCP was performed in 387 patients, 193 using laparoscopic approach and 194 robotic-assisted. For recurrence cases of POP, we took the criteria by International UroGynecological Association: direct or indirect genital prolapse reaching or going below the level of the hymen (POP-Q ≥ stage 2b) for objective recurrence. Functional outcomes were evaluated by international validated questionnaires by achieving the minimal clinical important difference (MCID) in points, previously approved by studies. Results: Our 3-year long-term outcomes resulted in 29 cases of POP recurrence (8.1%). Twenty-six of them were resulted in cystocele (7.3%), 4 (1.1%) in rectocele and 2 (0.6%) in apical prolapse. Clinical improvement based on Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire-12 (PISQ-12) score was met in 132 (66.3%) patients, 250 (70.0%) of women improved pelvic floor dysfunction Pelvic Floor Distress Inventory-20 (PFDI-20) and 205 (57.4%) of patients improved their social life according to Pelvic Floor Inventory Questionnaire-7 (PFIQ-7) score. Conclusions: Our long-term results reflect, that this method may not be advised in cases with anterior-apical prolapse, because of the high risk for prolapse recurrence (7.3%) and surgical imperfection of safe and avascular dissection of the anterior vaginal wall. However, in patients with complex and posterior-apical prolapse, such intervention still should be considered as a “gold standard”. 8","PeriodicalId":92781,"journal":{"name":"Gynecology and pelvic medicine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47522289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A narrative review of endometriosis surgery and infertility 子宫内膜异位症手术与不孕症的综述
Pub Date : 2021-01-01 DOI: 10.21037/GPM-20-55
U. Çoban, Ş. Hatırnaz, U. Kalkan
: Ectopic implantation of endometrial tissues outside of the endometrial layer is termed as endometriosis, which affects almost 10% of childbearing women, and the onset of pathogenesis goes back to the first menstrual bleeding. The frequency is increased to 25–50% in women diagnosed with infertility. The existence of endometriosis negatively effects fertility by many different pathways, but its surgical treatment may also decrease the potential for fertility. The goal of endometrioma surgery is to remove the cyst without tissue remnants and preserve the ovarian reserve as much as possible. In case of endometriosis if surgical intervention is a must for women with endometriosis, oocyte collection and embryo freezing before surgical intervention is recommended. Surgical intervention after fertility preservation in endometriosis minimizes the stress of the patient and surgeons feel safer during the surgical intervention. In patients with endometriosis, the choice of expectant management or surgical intervention should be individualized. In cases where the chance of spontaneous conception is high, surgery remains the primary option for appropriate treatment. Laparoscopic surgery is the preferred method for surgical removal of endometriotic lesions and surgery should be performed by skilled and specially trained surgeons. Deciding about the modality of endometriosis treatment is a controversial issue and preservation of fertility in women with endometriosis is fundamental. Each patient must be evaluated individually according to their symptoms, severity, age, expectations, and risks. 6
:异位植入子宫内膜层外的子宫内膜组织被称为子宫内膜异位症,它影响了近10%的育龄妇女,发病机制可以追溯到第一次月经出血。在被诊断为不孕的妇女中,这一频率增加到25-50%。子宫内膜异位症的存在通过许多不同的途径对生育能力产生负面影响,但其手术治疗也可能降低生育能力。子宫内膜瘤手术的目的是去除囊肿而不残留组织,并尽可能保留卵巢储备。如果子宫内膜异位症患者必须进行手术干预,建议在手术干预前采集卵母细胞并冷冻胚胎。子宫内膜异位症保留生育能力后的手术干预最大限度地减轻了患者的压力,外科医生在手术干预过程中感到更安全。对于子宫内膜异位症患者,应根据具体情况选择预期治疗或手术干预。在自发受孕几率很高的情况下,手术仍然是适当治疗的主要选择。腹腔镜手术是切除子宫内膜异位病变的首选方法,手术应由受过专门培训的熟练外科医生进行。决定子宫内膜异位症的治疗方式是一个有争议的问题,保持子宫内膜异位患者的生育能力是至关重要的。每个患者都必须根据其症状、严重程度、年龄、期望值和风险进行单独评估。6.
{"title":"A narrative review of endometriosis surgery and infertility","authors":"U. Çoban, Ş. Hatırnaz, U. Kalkan","doi":"10.21037/GPM-20-55","DOIUrl":"https://doi.org/10.21037/GPM-20-55","url":null,"abstract":": Ectopic implantation of endometrial tissues outside of the endometrial layer is termed as endometriosis, which affects almost 10% of childbearing women, and the onset of pathogenesis goes back to the first menstrual bleeding. The frequency is increased to 25–50% in women diagnosed with infertility. The existence of endometriosis negatively effects fertility by many different pathways, but its surgical treatment may also decrease the potential for fertility. The goal of endometrioma surgery is to remove the cyst without tissue remnants and preserve the ovarian reserve as much as possible. In case of endometriosis if surgical intervention is a must for women with endometriosis, oocyte collection and embryo freezing before surgical intervention is recommended. Surgical intervention after fertility preservation in endometriosis minimizes the stress of the patient and surgeons feel safer during the surgical intervention. In patients with endometriosis, the choice of expectant management or surgical intervention should be individualized. In cases where the chance of spontaneous conception is high, surgery remains the primary option for appropriate treatment. Laparoscopic surgery is the preferred method for surgical removal of endometriotic lesions and surgery should be performed by skilled and specially trained surgeons. Deciding about the modality of endometriosis treatment is a controversial issue and preservation of fertility in women with endometriosis is fundamental. Each patient must be evaluated individually according to their symptoms, severity, age, expectations, and risks. 6","PeriodicalId":92781,"journal":{"name":"Gynecology and pelvic medicine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46862507","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Overcoming challenges in minimally invasive gynecologic surgery 克服妇科微创手术的挑战
Pub Date : 2020-12-01 DOI: 10.21037/GPM-2020-PFD-01
Victoria Wesevich, E. Webster, S. Baxley
: Minimally invasive surgery (MIS) has gained widespread use over the past several decades and is now the prevailing surgical approach within gynecology through utilization of hysteroscopy, cystoscopy, laparoscopy, and vaginal surgery. A minimally invasive technique offers a number of benefits to patients, including improved postoperative recovery and superior cosmetic outcomes, and is becoming an increasingly recognized essential skill for all gynecologists. With appropriate precautions and preoperative planning, MIS has been shown to be a safe and effective option for gynecologic procedures. Certain patient populations may present specific challenges to the minimally invasive surgeon. In this article, we discuss commonly encountered challenges in gynecologic MIS. Given the effect that laparoscopy and positioning may have on organ physiology, we review preoperative planning and optimization for medically complex patients. Additionally, we discuss the approach to surgically complex patients, such as those with obesity, pregnancy, prior surgeries with associated scarring and adhesions, and other anatomic abnormalities. As MIS continues to be a growing and evolving field, we highlight novel surgical technologies and discuss the learning curve associated with adoption of new techniques. Through surgeon preparedness and experience, common pitfalls within the field of MIS may be avoided and patients may be provided with optimal care.
:微创手术(MIS)在过去几十年中得到了广泛的应用,通过宫腔镜、膀胱镜、腹腔镜和阴道手术,它现在是妇科的主流手术方法。微创技术为患者提供了许多好处,包括改善术后恢复和优越的美容效果,并正在成为所有妇科医生越来越认可的基本技能。通过适当的预防措施和术前计划,MIS已被证明是妇科手术的一种安全有效的选择。某些患者群体可能会对微创外科医生提出特定的挑战。在这篇文章中,我们讨论了妇科MIS中常见的挑战。考虑到腹腔镜检查和定位可能对器官生理产生的影响,我们回顾了医疗复杂患者的术前计划和优化。此外,我们还讨论了手术复杂患者的治疗方法,如肥胖、怀孕、既往手术伴有相关疤痕和粘连以及其他解剖异常的患者。随着MIS继续成为一个不断发展和发展的领域,我们强调了新的外科技术,并讨论了与采用新技术相关的学习曲线。通过外科医生的准备和经验,可以避免MIS领域的常见陷阱,并为患者提供最佳护理。
{"title":"Overcoming challenges in minimally invasive gynecologic surgery","authors":"Victoria Wesevich, E. Webster, S. Baxley","doi":"10.21037/GPM-2020-PFD-01","DOIUrl":"https://doi.org/10.21037/GPM-2020-PFD-01","url":null,"abstract":": Minimally invasive surgery (MIS) has gained widespread use over the past several decades and is now the prevailing surgical approach within gynecology through utilization of hysteroscopy, cystoscopy, laparoscopy, and vaginal surgery. A minimally invasive technique offers a number of benefits to patients, including improved postoperative recovery and superior cosmetic outcomes, and is becoming an increasingly recognized essential skill for all gynecologists. With appropriate precautions and preoperative planning, MIS has been shown to be a safe and effective option for gynecologic procedures. Certain patient populations may present specific challenges to the minimally invasive surgeon. In this article, we discuss commonly encountered challenges in gynecologic MIS. Given the effect that laparoscopy and positioning may have on organ physiology, we review preoperative planning and optimization for medically complex patients. Additionally, we discuss the approach to surgically complex patients, such as those with obesity, pregnancy, prior surgeries with associated scarring and adhesions, and other anatomic abnormalities. As MIS continues to be a growing and evolving field, we highlight novel surgical technologies and discuss the learning curve associated with adoption of new techniques. Through surgeon preparedness and experience, common pitfalls within the field of MIS may be avoided and patients may be provided with optimal care.","PeriodicalId":92781,"journal":{"name":"Gynecology and pelvic medicine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48048838","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Narrative review of hysteroscopy and endometriosis treatment 宫腔镜与子宫内膜异位症治疗的述评
Pub Date : 2020-11-02 DOI: 10.21037/GPM-2020-ES-01
R. Lasmar, B. Lasmar
Endometriosis is defined as the presence of endometrial glands and stroma located outside the uterine cavity. Adenomyosis is a benign uterine disease, characterized by the presence of glands and endometrial stroma in the uterine musculature. Hysteroscopy is indicated in patients diagnosed with endometriosis when there is also infertility, in the investigation of intrauterine causes of dysmenorrhea and abnormal uterine bleeding. The investigation of the uterine cavity by hysteroscopy will only be indicated in cases where the treatment of choice leads to uterine preservation, if there is an indication for hysterectomy, this investigation will not be necessary, except when there is suspicion of cervical or endometrial cancer. Literature review on endometriosis and uterine manifestations. Personal and college libraries searching for texts on research methods and literature reviews. Hysteroscopy is indicated in patients diagnosed with endometriosis when there is also infertility, in the investigation of intrauterine causes of dysmenorrhea and abnormal uterine bleeding. Endometrial polyps, myomas and uterine malformations are related to endometriosis. Those entities are related to infertility, pelvic pain and abnormal uterine bleeding. Hysteroscopy is able to diagnose and treat the majority of uterine lesions associated to endometriosis. Chronic endometritis, Endometrial Polyps, Myomas and uterine malformations should be investigated by hysteroscopy in patients with endometriosis.
子宫内膜异位症是指子宫腔外存在子宫内膜腺体和间质。子宫腺肌症是一种良性子宫疾病,其特征是子宫肌肉组织中存在腺体和子宫内膜间质。宫腔镜适用于诊断为子宫内膜异位症的患者同时存在不孕症时,在宫内探查引起痛经和子宫异常出血的原因。宫腔镜检查子宫腔只有在治疗选择导致保留子宫的情况下才有意义,如果有子宫切除术的指征,则不需要进行宫腔镜检查,除非怀疑有宫颈癌或子宫内膜癌。子宫内膜异位症及子宫表现的文献综述。个人和大学图书馆搜索文本的研究方法和文献评论。宫腔镜适用于诊断为子宫内膜异位症的患者同时存在不孕症时,在宫内探查引起痛经和子宫异常出血的原因。子宫内膜息肉、肌瘤和子宫畸形与子宫内膜异位症有关。这些实体与不孕、盆腔疼痛和子宫异常出血有关。宫腔镜能够诊断和治疗大多数与子宫内膜异位症相关的子宫病变。慢性子宫内膜炎、子宫内膜息肉、肌瘤及子宫畸形应在子宫内膜异位症患者行宫腔镜检查。
{"title":"Narrative review of hysteroscopy and endometriosis treatment","authors":"R. Lasmar, B. Lasmar","doi":"10.21037/GPM-2020-ES-01","DOIUrl":"https://doi.org/10.21037/GPM-2020-ES-01","url":null,"abstract":"Endometriosis is defined as the presence of endometrial glands and stroma located outside the uterine cavity. Adenomyosis is a benign uterine disease, characterized by the presence of glands and endometrial stroma in the uterine musculature. Hysteroscopy is indicated in patients diagnosed with endometriosis when there is also infertility, in the investigation of intrauterine causes of dysmenorrhea and abnormal uterine bleeding. The investigation of the uterine cavity by hysteroscopy will only be indicated in cases where the treatment of choice leads to uterine preservation, if there is an indication for hysterectomy, this investigation will not be necessary, except when there is suspicion of cervical or endometrial cancer. Literature review on endometriosis and uterine manifestations. Personal and college libraries searching for texts on research methods and literature reviews. Hysteroscopy is indicated in patients diagnosed with endometriosis when there is also infertility, in the investigation of intrauterine causes of dysmenorrhea and abnormal uterine bleeding. Endometrial polyps, myomas and uterine malformations are related to endometriosis. Those entities are related to infertility, pelvic pain and abnormal uterine bleeding. Hysteroscopy is able to diagnose and treat the majority of uterine lesions associated to endometriosis. Chronic endometritis, Endometrial Polyps, Myomas and uterine malformations should be investigated by hysteroscopy in patients with endometriosis.","PeriodicalId":92781,"journal":{"name":"Gynecology and pelvic medicine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45697503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vascular complication during staging lymphadenectomy in early-stage ovarian cancer 癌症早期淋巴结清扫术中的血管并发症
Pub Date : 2020-09-25 DOI: 10.21037/gpm-20-26
V. Capozzi, G. Armano, V. Ceni, M. Ricco’, N. Volpe, R. Berretta
Ovarian cancer (OC) is the fifth most frequent cancer in Europe and currently represents the main cause of death in women presenting gynecological cancer. In 70% of cases, the disease may be diagnosed at an advanced stage with nonspecific symptoms. In the early stages OC, surgical staging is needed to assess the extent of the disease. According to the National Comprehensive Cancer Network (NCCN), surgical staging includes total hysterectomy, bilateral salpingo-oophorectomy, omentectomy, peritoneal biopsies, and pelvic and lumboaortic lymphadenectomy. The classic surgical approach provides a median laparotomic longitudinal incision. However, in specialized centers, staging surgery may be performed through laparoscopic surgery for selected patients. Laparoscopic approach showed minor intra and postoperative complications, shorter hospital stay, faster return to work, and better aesthetic satisfaction when compared to laparotomic surgery. Nonetheless, even minimally invasive surgery is not without complications. In case of major complications occurring during laparoscopy rapid and prompt life-saving treatments could be necessary. We present a 63-year-old woman case with a 55 mm, multilocular-solid left adnexal mass, Color Score 2, with abnormal CA 125, requiring comprehensive staging surgery. The study aims to show a possible and dangerous vascular complication that may occur during staging lymphadenectomy in early-stage OC. In this case, a rapid laparotomic conversion was needed to quickly stop bleeding.
卵巢癌是欧洲第五大常见癌症,目前是妇科癌症妇女死亡的主要原因。在70%的病例中,疾病可能在非特异性症状的晚期被诊断出来。在早期OC,需要手术分期来评估疾病的程度。根据国家综合癌症网络(NCCN),手术分期包括全子宫切除术、双侧输卵管-卵巢切除术、网膜切除术、腹膜活检、盆腔和腰主动脉淋巴结切除术。经典的手术方法是剖腹正中纵切口。然而,在专业中心,可以通过腹腔镜手术对选定的患者进行分期手术。与开腹手术相比,腹腔镜入路术中及术后并发症少,住院时间短,恢复工作快,审美满意度高。然而,即使是微创手术也不是没有并发症的。如果在腹腔镜检查过程中发生重大并发症,快速和及时的挽救生命的治疗是必要的。我们报告一名63岁女性病例,她有一个55毫米的多房性左附件实性肿块,颜色评分2,CA 125异常,需要综合分期手术。本研究旨在揭示早期OC分期行淋巴结切除术时可能出现的危险血管并发症。在这种情况下,需要快速剖腹转换以快速止血。
{"title":"Vascular complication during staging lymphadenectomy in early-stage ovarian cancer","authors":"V. Capozzi, G. Armano, V. Ceni, M. Ricco’, N. Volpe, R. Berretta","doi":"10.21037/gpm-20-26","DOIUrl":"https://doi.org/10.21037/gpm-20-26","url":null,"abstract":"Ovarian cancer (OC) is the fifth most frequent cancer in Europe and currently represents the main cause of death in women presenting gynecological cancer. In 70% of cases, the disease may be diagnosed at an advanced stage with nonspecific symptoms. In the early stages OC, surgical staging is needed to assess the extent of the disease. According to the National Comprehensive Cancer Network (NCCN), surgical staging includes total hysterectomy, bilateral salpingo-oophorectomy, omentectomy, peritoneal biopsies, and pelvic and lumboaortic lymphadenectomy. The classic surgical approach provides a median laparotomic longitudinal incision. However, in specialized centers, staging surgery may be performed through laparoscopic surgery for selected patients. Laparoscopic approach showed minor intra and postoperative complications, shorter hospital stay, faster return to work, and better aesthetic satisfaction when compared to laparotomic surgery. Nonetheless, even minimally invasive surgery is not without complications. In case of major complications occurring during laparoscopy rapid and prompt life-saving treatments could be necessary. We present a 63-year-old woman case with a 55 mm, multilocular-solid left adnexal mass, Color Score 2, with abnormal CA 125, requiring comprehensive staging surgery. The study aims to show a possible and dangerous vascular complication that may occur during staging lymphadenectomy in early-stage OC. In this case, a rapid laparotomic conversion was needed to quickly stop bleeding.","PeriodicalId":92781,"journal":{"name":"Gynecology and pelvic medicine","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.21037/gpm-20-26","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41454821","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The vaginal microbiota, high-risk human papillomavirus infection, and cervical cytology: results from a population-based study 阴道微生物群、高危人乳头瘤病毒感染和宫颈细胞学:一项基于人群的研究结果
Pub Date : 2020-09-01 DOI: 10.21037/gpm-20-10
K. McKee, Kayla A. Carter, C. Bassis, V. Young, B. Reed, D. Harper, M. Ruffin, J. Bell
Background: The relationship between the vaginal microbiota, high-risk human papillomavirus infection, and abnormal cervical cytology has not been well characterized. Our objective was to characterize the vaginal microbiota in a stratified random sample of women from a population-based study in Appalachia. Methods: We analyzed a random sample of 308 women in the Community Access, Resources and Education: Project 3 study across 16 clinics in Ohio and West Virginia. Using Illumina MiSeq sequencing of 16S rRNA gene amplicons, we characterized the vaginal microbiota among (I) 109 women randomly chosen with abnormal cervical cytology (i.e., the majority were atypical squamous cells of undetermined significance (n=55) and low-grade squamous intraepithelial lesions (n=45) while n=6 were high-grade squamous intraepithelial lesions and n=3 were atypical glandular cells); (II) 110 high-risk human papillomavirus infection only without cytologic abnormality; and (III) 89 women from a stratified random sample without cytologic abnormalities (negative for intraepithelial lesion or malignancy or any human papillomavirus infection). Among the women with abnormal cervical cytology (n=109), 80 had human papillomavirus infection, the majority of which were positive for a high-risk type (n=61). Results: Nearly all of the women were non-Hispanic White (94.5%), and the mean age was 26 (IQR=21–39) years. Women with abnormal cervical cytology or who were HPV+ were more likely to have a diverse vaginal microbiota characterized by higher Gardnerella vaginalis relative abundance, compared to women without cytologic abnormalities whose communities were more likely to be Lactobacillus spp. dominant (P<0.04). Women without cytologic abnormalities had a higher prevalence of L. iners dominated communities than women with abnormal cervical cytology and HR HPV+ respectively (P<0.04), and L. gasseri relative abundance was differentially greater among these women compared to women with abnormal cervical cytology or who were high-risk HPV+ (Linear discriminant analysis effect size =4.17; P=0.0009). After adjustment for age, white race, current smoking, and ≥2 male partners in the last year, however, we did not detect differences in the vaginal microbiota community states across the three outcome groups. Conclusions: Compared to women without cytologic abnormalities, the vaginal microbiota of women with abnormal cervical cytology or who were high-risk HPV+ were characterized by a diverse community with increased relative abundance of G. vaginalis and reduced relative abundance of L. gasseri. However, these differences were attenuated after adjustment for other factors. Further study and validation of these differences for prognostic use is warranted.
背景:阴道微生物群、高危人乳头瘤病毒感染和宫颈细胞学异常之间的关系尚未得到很好的表征。我们的目的是在阿巴拉契亚地区的一项基于人群的研究中对女性进行分层随机抽样,以确定阴道微生物群的特征。方法:我们在俄亥俄州和西弗吉尼亚州的16个诊所的社区访问、资源和教育项目3研究中随机分析了308名妇女的样本。利用Illumina MiSeq对16S rRNA基因扩增子进行测序,我们对(I) 109名随机选择宫颈细胞学异常的女性进行了阴道微生物群的特征分析(即大多数为不确定意义的非典型鳞状细胞(n=55)和低级别鳞状上皮内病变(n=45), n=6为高级别鳞状上皮内病变,n=3为非典型腺细胞);(II) 110例高危人乳头瘤病毒感染,无细胞学异常;(III)分层随机抽样89名无细胞学异常(上皮内病变、恶性肿瘤或任何人类乳头瘤病毒感染阴性)的妇女。在宫颈细胞学异常的妇女(n=109)中,80人感染了人乳头瘤病毒,其中大多数为高危型阳性(n=61)。结果:几乎所有女性为非西班牙裔白人(94.5%),平均年龄为26岁(IQR= 21-39)。宫颈细胞学异常或HPV阳性的女性更有可能有多种阴道微生物群,其特征是阴道加德纳菌相对丰度较高,而没有细胞学异常的女性更有可能以乳酸杆菌为主(P<0.04)。无细胞学异常的妇女中,L. iners占主导地位的群落的患病率分别高于宫颈细胞学异常和HR HPV+的妇女(P<0.04),并且与宫颈细胞学异常或高危HPV+的妇女相比,这些妇女中L. gasseri的相对丰度差异更大(线性区分分析效应值=4.17;P = 0.0009)。然而,在调整了年龄、白人种族、当前吸烟和去年有≥2个男性伴侣后,我们没有发现三个结局组的阴道微生物群落状态存在差异。结论:与没有细胞学异常的女性相比,宫颈细胞学异常或高危HPV+的女性阴道微生物群具有多样化的群落特征,阴道G. vaginalis的相对丰度增加,L. gasseri的相对丰度降低。然而,在调整其他因素后,这些差异减弱了。有必要进一步研究和验证这些差异以用于预后。
{"title":"The vaginal microbiota, high-risk human papillomavirus infection, and cervical cytology: results from a population-based study","authors":"K. McKee, Kayla A. Carter, C. Bassis, V. Young, B. Reed, D. Harper, M. Ruffin, J. Bell","doi":"10.21037/gpm-20-10","DOIUrl":"https://doi.org/10.21037/gpm-20-10","url":null,"abstract":"Background: The relationship between the vaginal microbiota, high-risk human papillomavirus infection, and abnormal cervical cytology has not been well characterized. Our objective was to characterize the vaginal microbiota in a stratified random sample of women from a population-based study in Appalachia. Methods: We analyzed a random sample of 308 women in the Community Access, Resources and Education: Project 3 study across 16 clinics in Ohio and West Virginia. Using Illumina MiSeq sequencing of 16S rRNA gene amplicons, we characterized the vaginal microbiota among (I) 109 women randomly chosen with abnormal cervical cytology (i.e., the majority were atypical squamous cells of undetermined significance (n=55) and low-grade squamous intraepithelial lesions (n=45) while n=6 were high-grade squamous intraepithelial lesions and n=3 were atypical glandular cells); (II) 110 high-risk human papillomavirus infection only without cytologic abnormality; and (III) 89 women from a stratified random sample without cytologic abnormalities (negative for intraepithelial lesion or malignancy or any human papillomavirus infection). Among the women with abnormal cervical cytology (n=109), 80 had human papillomavirus infection, the majority of which were positive for a high-risk type (n=61). Results: Nearly all of the women were non-Hispanic White (94.5%), and the mean age was 26 (IQR=21–39) years. Women with abnormal cervical cytology or who were HPV+ were more likely to have a diverse vaginal microbiota characterized by higher Gardnerella vaginalis relative abundance, compared to women without cytologic abnormalities whose communities were more likely to be Lactobacillus spp. dominant (P<0.04). Women without cytologic abnormalities had a higher prevalence of L. iners dominated communities than women with abnormal cervical cytology and HR HPV+ respectively (P<0.04), and L. gasseri relative abundance was differentially greater among these women compared to women with abnormal cervical cytology or who were high-risk HPV+ (Linear discriminant analysis effect size =4.17; P=0.0009). After adjustment for age, white race, current smoking, and ≥2 male partners in the last year, however, we did not detect differences in the vaginal microbiota community states across the three outcome groups. Conclusions: Compared to women without cytologic abnormalities, the vaginal microbiota of women with abnormal cervical cytology or who were high-risk HPV+ were characterized by a diverse community with increased relative abundance of G. vaginalis and reduced relative abundance of L. gasseri. However, these differences were attenuated after adjustment for other factors. Further study and validation of these differences for prognostic use is warranted.","PeriodicalId":92781,"journal":{"name":"Gynecology and pelvic medicine","volume":"3 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.21037/gpm-20-10","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47833662","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Minimal invasive surgery in cervical cancer in the light of the LACC trial 基于LACC试验的宫颈癌微创手术
Pub Date : 2020-06-25 DOI: 10.21037/GPM-2020-05
D. Querleu, A. Rychlik
© Gynecology and Pelvic Medicine. All rights reserved. Gynecol Pelvic Med 2021;4:1 | http://dx.doi.org/10.21037/gpm-2020-05 After a recent publication in the New England Journal of Medicine the world of gynaecologic oncology was shaken by the reported safety issue of minimally invasive surgery (MIS) in the treatment of early cervical cancer. These so far widely used surgical techniques are characterized by fast recovery, short hospital stays, and less perioperative complications like blood loss, thrombosis and infections. The LACC trial, a phase III study published by Pedro Ramirez showed a significantly higher risk of relapse and death in patients with cervical cancer from 2 to 4 cm managed with minimal invasive surgery, with a 99% 3 years overall survival after open surgery 3 years, versus 93.8% after MIS (1). A national American database survey (2) provided similar findings. The LACC study has provided the only available level 1 evidence, and must be taken into account as a major source of knowledge and drive of clinical practice. However, the study was criticized, for several reasons. First of all methodological issues were identified: the primary statistical objective was not achieved; the confidence interval of the risk crosses the boundary of non-inferiority; the power of the study, which was interrupted after accruing 85% of the planned inclusions, is 84%, below the 90% standard of noninferiority trials (3). Furthermore, the power is automatically even lower when it comes to evaluating tumors smaller than 2 centimeters. Other criticisms were related to a substantial number of missing date, and differences in patients and tumor characteristics between groups, with a higher rate of parametrial involvement in the group of MIS (7% vs. 4%), non-standardized adjuvant treatment, higher rate of noncancer deaths in the laparoscopy group, and recurrence and mortality uncharacteristically low in open group. Finally the proficiency in MIS of the investigators was questioned, with an average of 2 cases per center per year. In contrast, many well-conduced retrospective studies such as a Korean study in a highly experienced center (4). A meta-analysis published in 2015 presented the outcome of 1,539 cervical cancer patients with similar prognosis for patients treated with open and MIS (5). In response to LACC trial many researchers started to collect their own data. Conflicting results were published, some confirming the findings of the LACC trial, others showing similar results whatever the approach. For example, a Swedish nationwide study did not show any difference in survival in 5-year observation, when robotic surgery was used compared to open approach (6). As robotic assistance has never been found to be superior to standard laparoscopic approach, this finding can be extrapolated to all modalities of MIS. A European Society of Gynaecologic Oncology (ESGO) study of a retrospective cohort found that while MIS seems to be detrimental in tumors larger
©妇科和盆腔医学。保留所有权利。Gynecol Pelvic Med 2021;4:1|http://dx.doi.org/10.21037/gpm-2020-05在最近发表在《新英格兰医学杂志》上后,妇科肿瘤学界因报道的微创手术(MIS)治疗早期宫颈癌症的安全性问题而震惊。到目前为止,这些广泛使用的手术技术具有恢复快、住院时间短、出血、血栓形成和感染等围手术期并发症较少的特点。Pedro Ramirez发表的LACC试验是一项III期研究,该研究表明,采用微创手术治疗的2至4厘米的癌症患者的复发和死亡风险显著较高,开放手术3年后的3年总生存率为99%,而MIS手术后的总生存率则为93.8%(1)。美国国家数据库调查(2)提供了类似的结果。LACC研究提供了唯一可用的1级证据,必须将其作为知识和临床实践驱动力的主要来源。然而,这项研究受到了批评,原因有几个。首先,确定了方法问题:主要统计目标没有实现;风险的置信区间跨越了非劣性的边界;该研究在获得85%的计划内含物后中断,其功效为84%,低于90%的非劣效性试验标准(3)。此外,当评估小于2厘米的肿瘤时,功率自动更低。其他批评与大量的漏诊日期、患者和肿瘤特征的差异有关,MIS组的子宫内膜受累率较高(7%对4%),非标准化辅助治疗,腹腔镜组的非癌症死亡率较高,开放组的复发率和死亡率异常低。最后,调查人员在MIS方面的熟练程度受到质疑,每个中心平均每年有2起案件。相比之下,许多进行得很好的回顾性研究,如在经验丰富的中心进行的韩国研究(4)。2015年发表的一项荟萃分析显示,1539名癌症患者的预后与接受开放和MIS治疗的患者相似(5)。作为对LACC试验的回应,许多研究人员开始收集自己的数据。发表了相互矛盾的结果,一些证实了LACC试验的结果,另一些则显示了类似的结果,无论采用何种方法。例如,瑞典的一项全国性研究表明,与开放式手术相比,使用机器人手术的5年观察期生存率没有任何差异(6)。由于从未发现机器人辅助优于标准腹腔镜方法,这一发现可以推广到MIS的所有模式。欧洲妇科肿瘤学会(ESGO)对一项回顾性队列研究发现,虽然MIS在大于2厘米的肿瘤中似乎是有害的,但MIS在较小尺寸的肿瘤和锥状活检后可能是安全的。后一项SUCCOR研究(癌症手术观察回顾性)收集了89个欧洲中心的数据(7)。与LACC试验相比,作者显示与MIS相关的肿瘤学风险更高(OS开放手术4.5年=98%,OS MIS po 4.5年=87%)。有趣的是,这些结果在肿瘤小于2cm的患者中没有得到证实,在锥形活检后,当不使用子宫操作器时,以及当进行保护性操作时[在手术开始时在肿瘤上闭合阴道(8),在袋子内进行标本提取,在手术结束时阴道进行阴道切开术]。一些小组已经开始了新的前瞻性试验,人们热切期待着结果。编辑评论
{"title":"Minimal invasive surgery in cervical cancer in the light of the LACC trial","authors":"D. Querleu, A. Rychlik","doi":"10.21037/GPM-2020-05","DOIUrl":"https://doi.org/10.21037/GPM-2020-05","url":null,"abstract":"© Gynecology and Pelvic Medicine. All rights reserved. Gynecol Pelvic Med 2021;4:1 | http://dx.doi.org/10.21037/gpm-2020-05 After a recent publication in the New England Journal of Medicine the world of gynaecologic oncology was shaken by the reported safety issue of minimally invasive surgery (MIS) in the treatment of early cervical cancer. These so far widely used surgical techniques are characterized by fast recovery, short hospital stays, and less perioperative complications like blood loss, thrombosis and infections. The LACC trial, a phase III study published by Pedro Ramirez showed a significantly higher risk of relapse and death in patients with cervical cancer from 2 to 4 cm managed with minimal invasive surgery, with a 99% 3 years overall survival after open surgery 3 years, versus 93.8% after MIS (1). A national American database survey (2) provided similar findings. The LACC study has provided the only available level 1 evidence, and must be taken into account as a major source of knowledge and drive of clinical practice. However, the study was criticized, for several reasons. First of all methodological issues were identified: the primary statistical objective was not achieved; the confidence interval of the risk crosses the boundary of non-inferiority; the power of the study, which was interrupted after accruing 85% of the planned inclusions, is 84%, below the 90% standard of noninferiority trials (3). Furthermore, the power is automatically even lower when it comes to evaluating tumors smaller than 2 centimeters. Other criticisms were related to a substantial number of missing date, and differences in patients and tumor characteristics between groups, with a higher rate of parametrial involvement in the group of MIS (7% vs. 4%), non-standardized adjuvant treatment, higher rate of noncancer deaths in the laparoscopy group, and recurrence and mortality uncharacteristically low in open group. Finally the proficiency in MIS of the investigators was questioned, with an average of 2 cases per center per year. In contrast, many well-conduced retrospective studies such as a Korean study in a highly experienced center (4). A meta-analysis published in 2015 presented the outcome of 1,539 cervical cancer patients with similar prognosis for patients treated with open and MIS (5). In response to LACC trial many researchers started to collect their own data. Conflicting results were published, some confirming the findings of the LACC trial, others showing similar results whatever the approach. For example, a Swedish nationwide study did not show any difference in survival in 5-year observation, when robotic surgery was used compared to open approach (6). As robotic assistance has never been found to be superior to standard laparoscopic approach, this finding can be extrapolated to all modalities of MIS. A European Society of Gynaecologic Oncology (ESGO) study of a retrospective cohort found that while MIS seems to be detrimental in tumors larger","PeriodicalId":92781,"journal":{"name":"Gynecology and pelvic medicine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48144514","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Robotic assistance for ureteral endometriosis resection and ureteroneocystostomy by the Leadbetter-Politano technique 机器人辅助输尿管子宫内膜异位症切除及输尿管膀胱造口术
Pub Date : 2020-06-25 DOI: 10.21037/gpm-20-2
T. Hébert, B. D'Arcier
Ureteral endometriosis is a rare location of this medical condition, found in 0.01% to 1% of all women diagnosed with the disease. Ureteral endometriosis can be a major concern due to its potential morbidity of silent loss of renal function. Deep infiltrative endometriosis (DIE) can be safely dealt with using robotic assistance. This video article is about a patient with a right low ureter stenosis caused by intrinsic endometriosis. Complete resection of endometriosis, including en-bloc resection of the lower part of the ureter was performed with robotic assistance. A robotically assisted ureteroneocystostomy by the LeadbetterPollitano technique was carried out for the reconstructive part of the procedure.
输尿管子宫内膜异位症是这种疾病的罕见部位,在所有被诊断患有该疾病的女性中,有0.01%至1%的人患有该疾病。输尿管子宫内膜异位症可能是一个主要的问题,因为它潜在的发病率是肾功能的无声丧失。深度浸润性子宫内膜异位症(DIE)可以使用机器人辅助安全处理。这篇视频文章是关于一位因子宫内膜异位症导致右下输尿管狭窄的患者。子宫内膜异位症的完全切除,包括输尿管下部的整体切除,都是在机器人辅助下进行的。在手术的重建部分,采用LeadbetterPollitano技术进行了机器人辅助输尿管新囊肿造口术。
{"title":"Robotic assistance for ureteral endometriosis resection and ureteroneocystostomy by the Leadbetter-Politano technique","authors":"T. Hébert, B. D'Arcier","doi":"10.21037/gpm-20-2","DOIUrl":"https://doi.org/10.21037/gpm-20-2","url":null,"abstract":"Ureteral endometriosis is a rare location of this medical condition, found in 0.01% to 1% of all women diagnosed with the disease. Ureteral endometriosis can be a major concern due to its potential morbidity of silent loss of renal function. Deep infiltrative endometriosis (DIE) can be safely dealt with using robotic assistance. This video article is about a patient with a right low ureter stenosis caused by intrinsic endometriosis. Complete resection of endometriosis, including en-bloc resection of the lower part of the ureter was performed with robotic assistance. A robotically assisted ureteroneocystostomy by the LeadbetterPollitano technique was carried out for the reconstructive part of the procedure.","PeriodicalId":92781,"journal":{"name":"Gynecology and pelvic medicine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46194235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hormonal treatments for preventing recurrence of endometriomas 激素治疗预防子宫内膜瘤复发
Pub Date : 2020-06-07 DOI: 10.21037/gpm-20-23
G. D’Alessandro, F. Barra, M. Tantari, S. Ferrero
Endometriosis is a chronic condition determined by the presence of ectopic endometrial glands and stroma. The disease affects approximately 10% of women of reproductive age and 35-50% of women with chronic pelvic pain and/or infertility. Transvaginal ultrasonography is a very sensitive and specific instrument for the diagnosis of endometrioma. Surgical and/or medical therapies for endometriomas aim to control symptoms (in particular, chronic pelvic pain and dysmenorrhea) and prevent cyst growth; medical therapy may be employed to reduce recurrence rate after surgery. After surgical approach, the reported postoperative recurrence rate of endometriomas is high, ranging from 30% to 40%; therefore, several hormonal therapies, such as oral contraceptives (OC), progestins (PG), GnRH analogs (GnRHa), and antagonists, danazol, aromatase inhibitors, selective estrogen receptor modulators (SERMs) and selective progesterone receptor modulators (SPRMs), have been employed in order to prevent disease recurrence. The objective of this systematic review is to assess the impact of the adjuvant use of hormonal treatment on endometrioma recurrence. Two evaluators extracted from MEDLINE, EMBASE, and Cochrane Library and reviewed published studies on this topic, following pre-determined selection criteria. Finally, data were extracted from 16 selected prospective or retrospective studies, of which 8 were randomized controlled trial and 8 were cohort studies. Most of them reported a beneficial impact on endometrioma recurrence by the usage of OC, PG, and GnRH analogs (GnRHa); however, conflicting results exist in the current literature about this topic. The duration of adjuvant therapy seems to have a crucial role in this context, but it is still not clear which type of postoperative hormonal treatment represents the best choice.
子宫内膜异位症是一种由子宫内膜腺体和间质异位引起的慢性疾病。该病影响约10%的育龄妇女和35-50%患有慢性盆腔疼痛和/或不孕症的妇女。经阴道超声检查是诊断子宫内膜异位瘤的一种非常敏感和特异的仪器。子宫内膜异位瘤的手术和/或药物治疗旨在控制症状(特别是慢性盆腔疼痛和痛经)和防止囊肿生长;药物治疗可降低术后复发率。手术入路后,子宫内膜异位瘤术后复发率高,30% ~ 40%不等;因此,一些激素治疗,如口服避孕药(OC),孕激素(PG), GnRH类似物(GnRHa),拮抗剂,达那唑,芳香化酶抑制剂,选择性雌激素受体调节剂(SERMs)和选择性孕激素受体调节剂(SPRMs),已被用于预防疾病复发。本系统综述的目的是评估辅助使用激素治疗对子宫内膜异位瘤复发的影响。两名评估人员从MEDLINE、EMBASE和Cochrane图书馆中提取,并按照预先确定的选择标准审查了有关该主题的已发表研究。最后,选取16项前瞻性或回顾性研究,其中8项为随机对照试验,8项为队列研究。其中大多数报告了使用OC、PG和GnRH类似物(GnRHa)对子宫内膜瘤复发的有益影响;然而,目前关于这一主题的文献中存在着相互矛盾的结果。在这种情况下,辅助治疗的持续时间似乎起着至关重要的作用,但目前尚不清楚哪种类型的术后激素治疗是最佳选择。
{"title":"Hormonal treatments for preventing recurrence of endometriomas","authors":"G. D’Alessandro, F. Barra, M. Tantari, S. Ferrero","doi":"10.21037/gpm-20-23","DOIUrl":"https://doi.org/10.21037/gpm-20-23","url":null,"abstract":"Endometriosis is a chronic condition determined by the presence of ectopic endometrial glands and stroma. The disease affects approximately 10% of women of reproductive age and 35-50% of women with chronic pelvic pain and/or infertility. Transvaginal ultrasonography is a very sensitive and specific instrument for the diagnosis of endometrioma. Surgical and/or medical therapies for endometriomas aim to control symptoms (in particular, chronic pelvic pain and dysmenorrhea) and prevent cyst growth; medical therapy may be employed to reduce recurrence rate after surgery. After surgical approach, the reported postoperative recurrence rate of endometriomas is high, ranging from 30% to 40%; therefore, several hormonal therapies, such as oral contraceptives (OC), progestins (PG), GnRH analogs (GnRHa), and antagonists, danazol, aromatase inhibitors, selective estrogen receptor modulators (SERMs) and selective progesterone receptor modulators (SPRMs), have been employed in order to prevent disease recurrence. The objective of this systematic review is to assess the impact of the adjuvant use of hormonal treatment on endometrioma recurrence. Two evaluators extracted from MEDLINE, EMBASE, and Cochrane Library and reviewed published studies on this topic, following pre-determined selection criteria. Finally, data were extracted from 16 selected prospective or retrospective studies, of which 8 were randomized controlled trial and 8 were cohort studies. Most of them reported a beneficial impact on endometrioma recurrence by the usage of OC, PG, and GnRH analogs (GnRHa); however, conflicting results exist in the current literature about this topic. The duration of adjuvant therapy seems to have a crucial role in this context, but it is still not clear which type of postoperative hormonal treatment represents the best choice.","PeriodicalId":92781,"journal":{"name":"Gynecology and pelvic medicine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47761938","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Of mice and men: pre-clinical models to identify therapy responsive patient subgroups 小鼠和男性:临床前模型,以确定治疗反应患者亚组
Pub Date : 2020-06-01 DOI: 10.21037/gpm.2020.04.01
Sarah B Gitto, D. Powell
© Gynecology and Pelvic Medicine. All rights reserved. Gynecol Pelvic Med 2020;3:13 | http://dx.doi.org/10.21037/gpm.2020.04.01 Ovarian cancer is the eighth leading cause of cancer related death among women, accounting for more than 150,000 deaths annually worldwide (1,2). High-grade serous ovarian cancer (HGSOC) is the most malignant form of ovarian cancer and accounts for approximately 70% of ovarian cancer diagnosis. Studies on cancer initiation, growth and metastasis have typically focused on genetic derangements in neoplastic cells; however, tumor growth cannot be exclusively explained by aberrations in cancer cells. Thus, it is of great interest to have a comprehensive understanding of how the tumor microenvironment (TME) promotes the neoplastic niche, and ultimately how to target the TME (including tumor stroma, extracellular matrix, and immune cells) to reduce disease recurrence and drug resistance. Historically, preclinical models focus on the genetic characteristics of the epithelial cells and have lacked in maintaining relevant TME components. In a recent study by Maniati et al. (3), the authors focused on characterizing the epithelial compartment and the TME of orthotropic syngeneic mouse tumor models to determine their analogy to patient tumors and to what extent these models can be utilized in preclinical studies that test TME targeting therapeutics. Six metastatic omental models of HGSOC were characterized. Two models, 30200 and 60577, were developed from genetically engineered mouse models (GEMMs) which had been engineered for Trp53, Brca and inactivation of the tumor suppressor function of Rb. Four additional models were developed from GEMMs with fallopian tube specific inducible inactivation of Brca2, Trp53, and Pten (models HGS1-4). RNA sequencing (RNAseq) analysis revealed nearly 1,300 differentially expressed genes [false discovery rate (FDR) <0.05] in the murine tumors compared to normal omental tissue. As expected, much of the tumor proliferation and survival pathways were significantly enriched (P<0.001). Copy number variation (CNV) frequently contributes to the alteration of oncogenic drivers or the deletion of tumor suppressors. HGSOC tumors have relatively more CNVs than many other tumor types, where patients have a medium fraction of 46% of their genome altered (4), compared to approximately 5–10% in various other cancer types (5). Typical preclinical models use immune-deficient HGSOC xenograft models with established cell lines. Much of the common cell lines used for in vivo modeling lack the CNV profiles that are commonly found in patient tumors further confirming a loss of genetic fidelity in historically used xenograft models. A study from Domcke et al. evaluating the genetic profile of 47 ovarian cell lines revealed profound differences in copy-number changes, mutations and mRNA expression of 12 of the most readily used Editorial Commentary
©妇科和盆腔医学。版权所有。妇科盆腔医学2020;3:13 | http://dx.doi.org/10.21037/gpm.2020.04.01卵巢癌是女性癌症相关死亡的第八大原因,全球每年有超过15万人死亡(1,2)。高级别浆液性卵巢癌(HGSOC)是最恶性的卵巢癌,约占卵巢癌诊断的70%。关于癌症发生、生长和转移的研究通常集中在肿瘤细胞的遗传紊乱上;然而,肿瘤的生长不能完全由癌细胞的畸变来解释。因此,全面了解肿瘤微环境(tumor microenvironment, TME)如何促进肿瘤生态位,最终如何针对TME(包括肿瘤间质、细胞外基质和免疫细胞)减少疾病复发和耐药,具有重要意义。以往,临床前模型关注上皮细胞的遗传特征,缺乏维持相关的TME成分。在Maniati等人(3)最近的一项研究中,作者着重描述了直向异性同基因小鼠肿瘤模型的上皮腔室和TME的特征,以确定它们与患者肿瘤的相似性,以及这些模型在多大程度上可用于临床前研究,以测试TME靶向治疗方法。我们对6种HGSOC转移性网膜模型进行了表征。30200和60577两种模型是在基因工程小鼠模型(GEMMs)的基础上开发的,这些模型经过Trp53、Brca和Rb抑癌功能失活的改造。另外四个模型是由输卵管特异性诱导Brca2、Trp53和Pten失活的GEMMs构建的(模型HGS1-4)。RNA测序(RNAseq)分析显示,与正常大网膜组织相比,小鼠肿瘤中有近1300个差异表达基因[错误发现率(false discovery rate, FDR) <0.05]。正如预期的那样,许多肿瘤增殖和存活途径显著富集(P<0.001)。拷贝数变异(CNV)经常导致致癌驱动因子的改变或肿瘤抑制因子的缺失。与许多其他肿瘤类型相比,HGSOC肿瘤具有相对更多的CNVs,其中患者的基因组有46%的中等比例改变(4),而在其他各种癌症类型中,这一比例约为5 - 10%(5)。典型的临床前模型使用具有已建立细胞系的免疫缺陷HGSOC异种移植模型。许多用于体内建模的常见细胞系缺乏在患者肿瘤中常见的CNV谱,进一步证实了在历史上使用的异种移植模型中遗传保真度的丧失。Domcke等人的一项研究评估了47种卵巢细胞系的遗传谱,揭示了12种最常用的编辑评论在拷贝数变化、突变和mRNA表达方面的深刻差异
{"title":"Of mice and men: pre-clinical models to identify therapy responsive patient subgroups","authors":"Sarah B Gitto, D. Powell","doi":"10.21037/gpm.2020.04.01","DOIUrl":"https://doi.org/10.21037/gpm.2020.04.01","url":null,"abstract":"© Gynecology and Pelvic Medicine. All rights reserved. Gynecol Pelvic Med 2020;3:13 | http://dx.doi.org/10.21037/gpm.2020.04.01 Ovarian cancer is the eighth leading cause of cancer related death among women, accounting for more than 150,000 deaths annually worldwide (1,2). High-grade serous ovarian cancer (HGSOC) is the most malignant form of ovarian cancer and accounts for approximately 70% of ovarian cancer diagnosis. Studies on cancer initiation, growth and metastasis have typically focused on genetic derangements in neoplastic cells; however, tumor growth cannot be exclusively explained by aberrations in cancer cells. Thus, it is of great interest to have a comprehensive understanding of how the tumor microenvironment (TME) promotes the neoplastic niche, and ultimately how to target the TME (including tumor stroma, extracellular matrix, and immune cells) to reduce disease recurrence and drug resistance. Historically, preclinical models focus on the genetic characteristics of the epithelial cells and have lacked in maintaining relevant TME components. In a recent study by Maniati et al. (3), the authors focused on characterizing the epithelial compartment and the TME of orthotropic syngeneic mouse tumor models to determine their analogy to patient tumors and to what extent these models can be utilized in preclinical studies that test TME targeting therapeutics. Six metastatic omental models of HGSOC were characterized. Two models, 30200 and 60577, were developed from genetically engineered mouse models (GEMMs) which had been engineered for Trp53, Brca and inactivation of the tumor suppressor function of Rb. Four additional models were developed from GEMMs with fallopian tube specific inducible inactivation of Brca2, Trp53, and Pten (models HGS1-4). RNA sequencing (RNAseq) analysis revealed nearly 1,300 differentially expressed genes [false discovery rate (FDR) <0.05] in the murine tumors compared to normal omental tissue. As expected, much of the tumor proliferation and survival pathways were significantly enriched (P<0.001). Copy number variation (CNV) frequently contributes to the alteration of oncogenic drivers or the deletion of tumor suppressors. HGSOC tumors have relatively more CNVs than many other tumor types, where patients have a medium fraction of 46% of their genome altered (4), compared to approximately 5–10% in various other cancer types (5). Typical preclinical models use immune-deficient HGSOC xenograft models with established cell lines. Much of the common cell lines used for in vivo modeling lack the CNV profiles that are commonly found in patient tumors further confirming a loss of genetic fidelity in historically used xenograft models. A study from Domcke et al. evaluating the genetic profile of 47 ovarian cell lines revealed profound differences in copy-number changes, mutations and mRNA expression of 12 of the most readily used Editorial Commentary","PeriodicalId":92781,"journal":{"name":"Gynecology and pelvic medicine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43339863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Gynecology and pelvic medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1